$VRUS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pharmasset Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pharmasset Inc. Get notifications about new insider transactions in Pharmasset Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 83.52 | 15,000 | 1,252,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 16.17 | 40,000 | 646,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 10.83 | 40,000 | 433,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 9.30 | 40,000 | 372,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 10.10 | 20,000 | 202,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 6.84 | 20,000 | 136,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 2.01 | 13,333 | 26,799 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | D | 1.50 | 53,333 | 80,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Sell | U | 137.00 | 22,000 | 3,014,000 | 0 | 22 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | D | 83.52 | 15,000 | 1,252,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | D | 16.17 | 40,000 | 646,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | D | 10.83 | 40,000 | 433,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | D | 9.30 | 40,000 | 372,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | D | 10.10 | 20,000 | 202,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Sell | U | 137.00 | 17,000 | 2,329,000 | 0 | 17 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 83.52 | 15,000 | 1,252,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 16.17 | 40,000 | 646,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 10.83 | 40,000 | 433,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 9.30 | 40,000 | 372,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 10.10 | 20,000 | 202,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 6.84 | 20,000 | 136,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | D | 3.38 | 6,667 | 22,534 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Carney William J | Director | Sell | U | 137.00 | 146,330 | 20,047,210 | 0 | 146.3 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | D | 83.52 | 15,000 | 1,252,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | D | 16.17 | 40,000 | 646,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | D | 10.83 | 20,000 | 216,600 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | D | 9.30 | 10,000 | 93,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | D | 10.10 | 3,750 | 37,875 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | D | 2.01 | 1 | 2 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Sell | U | 137.00 | 111,122 | 15,223,714 | 0 | 111.1 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Sell | U | 137.00 | 111,126 | 15,224,262 | 0 | 111.1 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Sell | U | 137.00 | 17,000 | 2,329,000 | 0 | 17 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 16.17 | 40,000 | 646,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 10.83 | 40,000 | 433,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 9.30 | 40,000 | 372,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 10.10 | 20,000 | 202,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 6.84 | 20,000 | 136,800 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 2.01 | 13,333 | 26,799 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 1.94 | 16,000 | 31,040 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | D | 1.94 | 13,333 | 25,866 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Sell | U | 137.00 | 7,000 | 959,000 | 0 | 7 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 83.52 | 75,000 | 6,264,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 16.17 | 59,000 | 954,030 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 10.83 | 50,000 | 541,500 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 9.30 | 20,000 | 186,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 6.84 | 62,000 | 424,080 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 2.01 | 51,000 | 102,510 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 1.94 | 68,500 | 132,890 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | D | 1.50 | 125,000 | 187,500 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Sell | U | 137.00 | 75,300 | 10,316,100 | 0 | 75.3 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Sell | U | 137.00 | 75,300 | 10,316,100 | 0 | 75.3 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Sell | U | 137.00 | 222,232 | 30,445,784 | 0 | 222.2 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | D | 83.52 | 75,000 | 6,264,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | D | 16.17 | 59,000 | 954,030 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | D | 10.83 | 25,000 | 270,750 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | D | 9.30 | 9,376 | 87,197 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | D | 2.10 | 98,217 | 206,256 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 83.52 | 210,000 | 17,539,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 16.17 | 166,600 | 2,693,922 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 10.83 | 100,000 | 1,083,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 9.30 | 60,000 | 558,000 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 6.84 | 186,000 | 1,272,240 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 4.50 | 133,332 | 599,994 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 2.01 | 160,000 | 321,600 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 1.94 | 68,751 | 133,377 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | D | 1.50 | 371,915 | 557,873 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | U | 137.00 | 69,260 | 9,488,620 | 0 | 69.3 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | U | 137.00 | 69,260 | 9,488,620 | 0 | 69.3 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | U | 137.00 | 628,044 | 86,042,028 | 0 | 628 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 83.52 | 60,000 | 5,011,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 16.17 | 50,000 | 808,500 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 10.83 | 22,500 | 243,675 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 9.30 | 12,142 | 112,921 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 6.84 | 27,442 | 187,703 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 2.01 | 10,000 | 20,100 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | D | 1.50 | 1 | 2 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | U | 137.00 | 14,378 | 1,969,786 | 0 | 14.4 K to 0 (-100.00 %) |
Jan 17 2012 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | D | 83.52 | 60,000 | 5,011,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | D | 16.17 | 50,000 | 808,500 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | D | 10.83 | 40,000 | 433,200 | 0 | |
Jan 17 2012 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | D | 6.94 | 52,500 | 364,350 | 0 | |
Dec 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 10.83 | 3,126 | 33,839 | 25,000 | |
Dec 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 6.84 | 3,126 | 21,366 | 0 | |
Dec 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 130.33 | 3,126 | 407,412 | 0 | 3.1 K to 0 (-100.00 %) |
Dec 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 10.83 | 3,126 | 33,839 | 3,126 | 0 to 3.1 K |
Dec 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 130.33 | 3,126 | 407,412 | 0 | 3.1 K to 0 (-100.00 %) |
Dec 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 6.84 | 3,126 | 21,366 | 3,126 | 0 to 3.1 K |
Nov 07 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | M | 10.83 | 17,500 | 189,525 | 0 | |
Nov 07 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | S | 74.56 | 17,500 | 1,304,800 | 0 | 17.5 K to 0 (-100.00 %) |
Nov 07 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Buy | M | 10.83 | 17,500 | 189,525 | 17,500 | 0 to 17.5 K |
Nov 03 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 6.84 | 3,124 | 21,353 | 3,126 | |
Nov 03 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 74.56 | 3,124 | 232,925 | 0 | 3.1 K to 0 (-100.00 %) |
Nov 03 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 6.84 | 3,124 | 21,353 | 3,124 | 0 to 3.1 K |
Oct 13 2011 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | A | 83.52 | 15,000 | 1,252,800 | 15,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Grant | A | 0.00 | 1,000 | 0 | 7,000 | 6 K to 7 K (+16.67 %) |
Oct 13 2011 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | A | 83.52 | 15,000 | 1,252,800 | 15,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | Carney William J | Director | Grant | A | 0.00 | 1,000 | 0 | 146,330 | 145.3 K to 146.3 K (+0.69 %) |
Oct 13 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | A | 83.52 | 60,000 | 5,011,200 | 60,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President & CEO | Option Exercise | A | 83.52 | 210,000 | 17,539,200 | 210,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | A | 83.52 | 60,000 | 5,011,200 | 60,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | A | 83.52 | 75,000 | 6,264,000 | 75,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | A | 83.52 | 15,000 | 1,252,800 | 15,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Grant | A | 0.00 | 1,000 | 0 | 22,000 | 21 K to 22 K (+4.76 %) |
Oct 13 2011 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | A | 83.52 | 15,000 | 1,252,800 | 15,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Grant | A | 0.00 | 1,000 | 0 | 43,666 | 42.7 K to 43.7 K (+2.34 %) |
Oct 13 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | A | 83.52 | 75,000 | 6,264,000 | 75,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | A | 83.52 | 15,000 | 1,252,800 | 15,000 | |
Oct 13 2011 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Grant | A | 0.00 | 1,000 | 0 | 17,000 | 16 K to 17 K (+6.25 %) |
Oct 05 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President & CEO | Option Exercise | M | 1.50 | 40,000 | 60,000 | 371,915 | |
Oct 05 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President & CEO | Sell | S | 79.33 | 40,000 | 3,173,316 | 766,564 | 806.6 K to 766.6 K (-4.96 %) |
Oct 05 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President & CEO | Buy | M | 1.50 | 40,000 | 60,000 | 806,564 | 766.6 K to 806.6 K (+5.22 %) |
Sep 06 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 10.83 | 3,124 | 33,817 | 28,126 | |
Sep 06 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 65.63 | 3,124 | 205,015 | 0 | 3.1 K to 0 (-100.00 %) |
Sep 06 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 10.83 | 3,124 | 33,817 | 3,124 | 0 to 3.1 K |
Sep 06 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | M | 1.50 | 40,000 | 60,000 | 411,915 | |
Sep 06 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | S | 65.63 | 40,000 | 2,625,032 | 766,566 | 806.6 K to 766.6 K (-4.96 %) |
Sep 06 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Buy | M | 1.50 | 40,000 | 60,000 | 806,566 | 766.6 K to 806.6 K (+5.22 %) |
Aug 03 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 18.60 | 937 | 17,428 | 4,688 | |
Aug 03 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 119.99 | 937 | 112,431 | 0 | 937 to 0 (-100.00 %) |
Aug 03 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 18.60 | 937 | 17,428 | 937 | 0 to 937 |
Aug 03 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | M | 3.00 | 20,000 | 60,000 | 225,957 | |
Aug 03 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | S | 120.15 | 20,000 | 2,403,006 | 383,283 | 403.3 K to 383.3 K (-4.96 %) |
Aug 03 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Buy | M | 3.00 | 20,000 | 60,000 | 403,283 | 383.3 K to 403.3 K (+5.22 %) |
Aug 03 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Option Exercise | M | 18.60 | 8,929 | 166,079 | 6,071 | |
Aug 03 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | S | 119.99 | 8,929 | 1,071,391 | 7,189 | 16.1 K to 7.2 K (-55.40 %) |
Aug 03 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Buy | M | 18.60 | 8,929 | 166,079 | 16,118 | 7.2 K to 16.1 K (+124.20 %) |
Jul 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 18.60 | 938 | 17,447 | 5,625 | |
Jul 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 111.83 | 938 | 104,897 | 0 | 938 to 0 (-100.00 %) |
Jul 05 2011 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 18.60 | 938 | 17,447 | 938 | 0 to 938 |
Jul 05 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | M | 3.00 | 20,000 | 60,000 | 245,957 | |
Jul 05 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | S | 110.47 | 20,000 | 2,209,326 | 383,283 | 403.3 K to 383.3 K (-4.96 %) |
Jul 05 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Buy | M | 3.00 | 20,000 | 60,000 | 403,283 | 383.3 K to 403.3 K (+5.22 %) |
Jun 03 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | M | 3.00 | 20,000 | 60,000 | 265,957 | |
Jun 03 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Sell | S | 100.54 | 20,000 | 2,010,706 | 383,283 | 403.3 K to 383.3 K (-4.96 %) |
Jun 03 2011 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Buy | M | 3.00 | 20,000 | 60,000 | 403,283 | 383.3 K to 403.3 K (+5.22 %) |
May 11 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | M | 13.88 | 10,000 | 138,800 | 26,250 | |
May 11 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 109.08 | 10,000 | 1,090,800 | 0 | 10 K to 0 (-100.00 %) |
May 11 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Buy | M | 13.88 | 10,000 | 138,800 | 10,000 | 0 to 10 K |
May 10 2011 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Sell | S | 102.88 | 11,287 | 1,161,207 | 186,417 | 197.7 K to 186.4 K (-5.71 %) |
May 10 2011 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | M | 3.00 | 20,000 | 60,000 | 0 | |
May 10 2011 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Sell | S | 104.36 | 31,666 | 3,304,607 | 3,000 | 34.7 K to 3 K (-91.35 %) |
May 10 2011 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Buy | M | 3.00 | 20,000 | 60,000 | 34,666 | 14.7 K to 34.7 K (+136.37 %) |
May 09 2011 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Sell | S | 102.61 | 9,546 | 979,515 | 197,704 | 207.3 K to 197.7 K (-4.61 %) |
May 05 2011 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | M | 17.55 | 40,000 | 702,000 | 0 | |
May 05 2011 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Sell | S | 99.04 | 40,000 | 3,961,584 | 8,000 | 48 K to 8 K (-83.33 %) |
May 05 2011 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Buy | M | 17.55 | 40,000 | 702,000 | 48,000 | 8 K to 48 K (+500.00 %) |
Apr 29 2011 | VRUS | Pharmasset Inc | OTTO MICHAEL J. | Chief Scientific Of ... | Sell | S | 99.85 | 9,500 | 948,575 | 7,189 | 16.7 K to 7.2 K (-56.92 %) |
Apr 29 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | M | 13.88 | 20,000 | 277,600 | 36,250 | |
Apr 29 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 99.00 | 20,000 | 1,980,068 | 0 | 20 K to 0 (-100.00 %) |
Apr 29 2011 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Buy | M | 13.88 | 20,000 | 277,600 | 20,000 | 0 to 20 K |